MOA Life Plus Co. Ltd. (KOSDAQ: A142760)
Health Care · Biotechnology · KR
₩520.00
+0.78% today · -85.0% 1Y
MOA Life Plus Co. Ltd. (KOSDAQ: A142760) operates in the Biotechnology industry within the Health Care sector. The company is valued at $8.22M.
Over the last twelve months the share price has lost 85.0%, trading between 441.00 and 3.79K.
Tweenvest scores MOA Life Plus Co. Ltd. across four factors: quality 53/100, value 43/100, growth 0/100. Its strongest factor is quality.
A142760 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $8.22M
- Revenue (TTM)
- $6.75M
- P/E
- —
- EPS
- -704.88
- Dividend yield
- —
- Beta (5Y)
- 0.58
- 52-week high
- ₩3,788.00
- 52-week low
- ₩441.00
- Avg volume (3M)
- —
- Shares outstanding
- 21.08M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Adaptimmune Therapeutics plcOTCPK: ADAP.Y | $8.48M | $0.03 | +6.67% |
| Eusol Biotech Co.,Ltd.UNQ: 6652 | $8.45M | NT$— | — |
| Active Biotech AB (publ)OM: ACTI | $8.34M | Skr3.14 | -10.94% |
| MetaVia Inc.NasdaqCM: MTVA | $8.30M | $1.26 | -10.64% |
| NFL Biosciences SAENXTPA: ALNFL | $8.08M | €0.57 | -8.55% |
| Vivesto ABOM: VIVE | $8.06M | Skr7.21 | -3.74% |
| OSR Health, Inc.OTCPK: OSRH | $7.94M | $0.23 | +15.90% |
| Delta-Fly Pharma, Inc.TSE: 4598 | $7.86M | ¥84.00 | -15.15% |
Figures last refreshed Oct 18, 2026.